Cabozantinib S-Malate
Brand name: Cabometyx
Rank #62 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$287.3M
Total Cost
11,285
Total Claims
$287.3M
Total Cost
533
Prescribers
$25K
Cost per Claim
331
Beneficiaries
11,329
30-Day Fills
$539K
Avg Cost/Provider
21
Avg Claims/Provider
Share of Medicare Part D Spending
0.10%
of total Medicare Part D spending
$287.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $287.3M total
🔎 Data Overview
At $25,461 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $539,071 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $868,051 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Cabozantinib S-Malate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Adanma Anji Ayanambakkam Attanathi | Hematology-Oncology | Oklahoma City, OK | 101 | $2.7M |
| 2 | Ajay Sehgal | Hematology-Oncology | Corpus Christi, TX | 82 | $2.2M |
| 3 | Daniel George | Hematology-Oncology | Durham, NC | 95 | $2.2M |
| 4 | Moshe Ornstein | Hematology-Oncology | Cleveland, OH | 111 | $2.2M |
| 5 | Robert Alter | Hematology-Oncology | Hackensack, NJ | 94 | $2.0M |
| 6 | Meredith Morgan | Nurse Practitioner | Nashville, TN | 86 | $1.9M |
| 7 | Tarenne Carrington | Nurse Practitioner | Philadelphia, PA | 80 | $1.9M |
| 8 | Munveer Bhangoo | Hematology-Oncology | La Jolla, CA | 66 | $1.8M |
| 9 | Chandler Park | Hematology-Oncology | Corydon, IN | 68 | $1.8M |
| 10 | Song Zhao | Medical Oncology | Seattle, WA | 66 | $1.7M |
| 11 | Leah Shaw | Nurse Practitioner | Houston, TX | 66 | $1.7M |
| 12 | John Burfeind | Hematology-Oncology | West Bend, WI | 65 | $1.6M |
| 13 | Brian Rini | Hematology-Oncology | Nashville, TN | 60 | $1.6M |
| 14 | Khawaja Jahangir | Hematology-Oncology | Las Vegas, NV | 48 | $1.6M |
| 15 | Shi-Ming Tu | Medical Oncology | Houston, TX | 69 | $1.6M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 59 | Tofacitinib Citrate (Xeljanz Xr) | $294.4M | 49,478 |
| 60 | Umeclidinium Brm/Vilanterol Tr (Anoro Ellipta) | $294.3M | 480,651 |
| 61 | Gabapentin (Gabapentin) | $291.0M | 15,142,335 |
| 62 | Cabozantinib S-Malate (Cabometyx) | $287.3M | 11,285 |
| 63 | Rsv Vacc, Pref A And Pref B/Pf (Abrysvo) | $284.5M | 872,396 |
| 64 | Bimatoprost (Lumigan) | $284.4M | 610,243 |
| 65 | Apremilast (Otezla) | $283.9M | 59,020 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology